Cargando…
Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
Autores principales: | Hill, Richard, Madureira, Patricia A., Ferreira, Bibiana, Baptista, Inês, Machado, Susana, Colaҫo, Laura, dos Santos, Marta, Liu, Ningshu, Dopazo, Ana, Ugurel, Selma, Adrienn, Angyal, Kiss-Toth, Endre, Isbilen, Murat, Gure, Ali O., Link, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356827/ https://www.ncbi.nlm.nih.gov/pubmed/37468494 http://dx.doi.org/10.1038/s41467-023-40050-1 |
Ejemplares similares
-
TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
por: Hill, Richard, et al.
Publicado: (2017) -
Tribbles homolog 2 (Trib2), a pseudo serine/threonine kinase in tumorigenesis and stem cell fate decisions
por: Fang, Yu, et al.
Publicado: (2021) -
Evidence for a role of TRIB3 in the regulation of megakaryocytopoiesis
por: Butcher, Lee, et al.
Publicado: (2017) -
Harmine and Piperlongumine Revert TRIB2-Mediated Drug Resistance
por: Machado, Susana, et al.
Publicado: (2020) -
Comprehensive Profiling of Mammalian Tribbles Interactomes Implicates TRIB3 in Gene Repression
por: Hernández-Quiles, Miguel, et al.
Publicado: (2021)